Muscle News and Research

RSS

Alnylam presents positive ongoing phase 2 open-label extension data for Patisiran and Revusiran

Alnylam Pharmaceuticals, Inc. has announced new results from its ongoing Phase 2 open-label extension (OLE) studies with patisiran and revusiran, investigational RNAi therapeutics targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR amyloidosis).

3 Nov 2015

$Older people with age-related muscle loss face greater risk of falls, bone fractures$

Older people with age-related muscle loss face greater risk of falls, bone fractures

Older people with an age-related loss of muscle mass and strength may be at greater risk of falling and bone fractures, according to new research led by the University of Southampton.

3 Nov 2015

$Viking begins VK5211 Phase 2 trial in patients recovering from hip fracture$

Viking begins VK5211 Phase 2 trial in patients recovering from hip fracture

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders, today announced the initiation of dosing in the company's Phase 2 clinical trial of VK5211 in patients who recently suffered a hip fracture.

3 Nov 2015

Experts call on U.S. and Mexican governments to reduce risk of Chagas disease

Chagas disease -- the third most common parasitic infection in the world -- affects approximately 7.5 million people, mostly in Latin America. To help reduce outbreaks of this disease in their countries, the United States and Mexican governments should implement a range of programs as well as fund research for the development of Chagas vaccines and treatments, according to a new policy brief by tropical-disease and science policy experts at Rice University's Baker Institute for Public Policy.

3 Nov 2015

Key protein controls stem cell properties that could make them useful in regenerative medicine

A key protein controls stem cell properties that could make them more useful in regenerative medicine, according to a study led by Mount Sinai researchers and published online today in the journal Cell Stem Cell.

31 Oct 2015

Prkci gene maintains balance in stem cell production

When it comes to stem cells, too much of a good thing isn't wonderful: producing too many new stem cells may lead to cancer; producing too few inhibits the repair and maintenance of the body.

31 Oct 2015

Miriam Hospital enrolling local participants for Parachute implant clinical trial to treat heart failure

The Miriam Hospital is actively recruiting local participants for a U.S. clinical trial of the Parachute device for treating heart failure. The study is focused on determining if the new minimally invasive catheter-based device can slow the progression of heart failure, reduce repeat hospitalizations and death, and significantly improve quality of life for patients who experience enlargement of the left ventricle after a heart attack.

31 Oct 2015

Johns Hopkins doctors urge people to get vaccinated against influenza virus

Flu season is upon us again — and yes, you should get the flu vaccine. Doctors at the Johns Hopkins University School of Medicine say everyone 6 months of age and older should get vaccinated against the influenza virus this year.

31 Oct 2015

Conventional methods may underestimate cardiorespiratory fitness, muscular strength in people with MS

Conventional methods of assessing cardiorespiratory fitness and muscular strength among people with multiple sclerosis may underestimate participants' capabilities, prompting clinicians to prescribe exercise therapies that are less effective than they could be, according to new research by scientists at the University of Illinois.

31 Oct 2015

Lack of adequate sleep can interfere with fundamental cellular process

Lack of adequate sleep can do more than just make you tired. It can short-circuit your system and interfere with a fundamental cellular process that drives physical growth, physiological adaptation and even brain activity, according to a new study from the University of Tennessee, Knoxville.

30 Oct 2015

Vertical jump could predict lower body bone strength in adolescents

Every year at least 250,000 older Americans are hospitalized for hip fractures. It is hard to recover from a hip fracture, and many people lose their independence afterward. Low bone strength during the growing the years can lead to a greater chance of having a hip fracture as an older adult.

30 Oct 2015

President and CEO of Protein Sciences elected as 2015 Fellow of the International Society for Vaccines

Protein Sciences Corporation, the makers of Flublok Influenza Vaccine, announced today that Dr. Manon Cox, President and CEO, was elected as a 2015 Fellow of the International Society for Vaccines (ISV). The ISV is an esteemed organization dedicated to the development, advancement and use of vaccines to prevent and control disease.

30 Oct 2015

Novartis announces FDA approval of dual combination bronchodilator Utibron Neohaler for COPD patients

Novartis announced today that the US Food and Drug Administration has approved the dual combination bronchodilator Utibron Neohaler (indacaterol/glycopyrrolate) inhalation powder for the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. It is not indicated to treat asthma or sudden symptoms of COPD.

30 Oct 2015

Franziska Michor named recipient of NYSCF - Robertson Stem Cell Prize

The New York Stem Cell Foundation announced today that Franziska Michor, PhD, is the 2015 recipient of the NYSCF - Robertson Stem Cell Prize for her work pioneering new approaches to study the growth, spread, and treatment of cancer. Her laboratory fuses her passions in mathematics, molecular biology and patient care to investigate how cancers form and progress.

29 Oct 2015

Weight and physical activity level matter in kids' ability to think

Weight and physical activity levels are both factors in a child's ability to acquire and use knowledge, a new study finds.

28 Oct 2015

Infections with Lone star ticks appear to be surging but deaths are not, new study reveals

A mild disease spread by the aggressive Lone star tick that is now colonizing large swaths of the United States is being mistaken for Rocky Mountain spotted fever, according to a new study from scientists at the U.S. Centers for Disease Control and Prevention.

28 Oct 2015

U-M study suggests new therapeutic strategy for treating Duchene muscular dystrophy

Every heart beat and step in our daily lives is dependent on the integrity of muscles and the proteins that keep them strong and free of injury as they contract and relax.

27 Oct 2015

Noninvasive CT scans far better than stress tests at spotting clogged arteries

Results of a head-to-head comparison study led by Johns Hopkins researchers show that noninvasive CT scans of the heart's vessels are far better at spotting clogged arteries that can trigger a heart attack than the commonly prescribed exercise stress that most patients with chest pain undergo.

27 Oct 2015

Mast Therapeutics begins vepoloxamer Phase 2 study in patients with chronic heart failure

Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company leveraging its molecular adhesion and sealant technology (MAST) platform to develop novel therapies for sickle cell disease, heart failure, and stroke, announced that it has initiated its Phase 2 study of vepoloxamer for the treatment of patients with chronic heart failure.

26 Oct 2015

Heart disease becomes the major killer of women in Norway

More research is carried out on breast cancer than on women's heart attack. Even though heart attack kills more women.

26 Oct 2015

Muscle News and Research

Alnylam presents positive ongoing phase 2 open-label extension data for Patisiran and Revusiran

Older people with age-related muscle loss face greater risk of falls, bone fractures

Viking begins VK5211 Phase 2 trial in patients recovering from hip fracture

Experts call on U.S. and Mexican governments to reduce risk of Chagas disease

Key protein controls stem cell properties that could make them useful in regenerative medicine

Prkci gene maintains balance in stem cell production

Miriam Hospital enrolling local participants for Parachute implant clinical trial to treat heart failure

Johns Hopkins doctors urge people to get vaccinated against influenza virus

Conventional methods may underestimate cardiorespiratory fitness, muscular strength in people with MS

Lack of adequate sleep can interfere with fundamental cellular process

Vertical jump could predict lower body bone strength in adolescents

President and CEO of Protein Sciences elected as 2015 Fellow of the International Society for Vaccines

Novartis announces FDA approval of dual combination bronchodilator Utibron Neohaler for COPD patients

Franziska Michor named recipient of NYSCF - Robertson Stem Cell Prize

Weight and physical activity level matter in kids' ability to think

Infections with Lone star ticks appear to be surging but deaths are not, new study reveals

U-M study suggests new therapeutic strategy for treating Duchene muscular dystrophy

Noninvasive CT scans far better than stress tests at spotting clogged arteries

Mast Therapeutics begins vepoloxamer Phase 2 study in patients with chronic heart failure

Heart disease becomes the major killer of women in Norway

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News